Adam Majewski

Adam Majewski

Auto-generated profile, based on publicly available information

Adam Majewski

Medical University of Lublin

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2026 in Current Issues in Pharmacy and Medical Sciences
Verified
Journal Article
Open access
PDF file
AMAdam Majewski
Adam Majewski
TOTomasz
Tomasz
ASAnna Serefko
Anna Serefko
JSJan Sobczyński
Jan Sobczyński
Aleksandra SzopaAleksandra Szopa
Aleksandra Szopa
This paper aims to present the historical determinants of the development of the legal basis of pharmacy in Poland from the tenth century until the nationalization of pharmacies in 1951. Specifically, the paper describes how major historical events, including the partitions, influenced the healthcare system and pharmacies. A literature review was conducted using the PubMed database from its inception to September 2022, as well as Google Scholar. The Online Legal Database (ISAP) was also used in these studies. Following the Third Partition of Poland, Polish territories were divided among Russia, Prussia, and Austria. Foreign legal regimes were introduced in Poland, and pharmacies were subject to the jurisdiction of the partitioning powers. After Poland regained independence in 1918, the partition laws were not abolished while a new organizational structure for the healthcare system was being established. Poland inherited three pharmacy systems after the partitions, all of which were based on a concession system. Although government bills were prepared to create a unified pharmacy system, the Second World War halted these efforts. During the war, the health service was reorganized according to current German laws. In the early postwar years, the pharmaceutical service was reorganized as the foundations of the new health service were constructed. The pharmacy network expanded, and pharmacy chambers were established. The nationalization of pharmacies and the subsequent collapse of individual pharmacies was a turning point in the history of Polish pharmacy. This change in regulation altered the image of Polish pharmacies and reduced the prestige of the profession. Following Poland's political transformation in 1989, key legislation shaping today's pharmacies took effect. A period of dynamic socioeconomic changes also began in pharmacies and continues to this day. The results presented in the manuscript demonstrate that Poland’s lack of independence and World War II played an important role in shaping pharmacy ownership and operation in subsequent years.

2 April 2025 in Zdrowie Publiczne i Zarządzanie
Verified
Journal Article
Open access
PDF file
MTMarek Tomków
Marek Tomków
Radosław BalwierzRadosław Balwierz
Radosław Balwierz
AMAdam Majewski
Adam Majewski
Aleksandra SzopaAleksandra Szopa
Aleksandra Szopa
For over twenty years, pharmacists in Poland did not have the right to perform even simple diagnostic tests, such as measuring blood pressure or patient’s body weight. It was only during the COVID-19 pandemic that the law was changed to allow the introduction of pharmaceutical care services in pharmacies, which enabled diagnostic tests to be performed, including tests for the SARS-CoV-2 virus. As a result, pharmacies performed 89,984 tests, of which 49,345 only in February 2022. The cessation of financing for this service by the National Health Fund (NFZ) on April 1, 2022 resulted in a significant decrease in the number of tests performed. A legal and comparative analysis of legal acts in force since 2001 was carried out, along with an analysis of data obtained from the E-Health Center. It has been shown that the change in regulations both regarding the qualifications of pharmacists and the financing of tests for the SARS-CoV-2 virus increased the number of diagnostic tests performed. Therefore, increasing the rights of pharmacists to perform diagnostic tests is the right direction of changes in the health care system in Poland.

1 March 2024 in Current Issues in Pharmacy and Medical Sciences
Verified
Journal Article
Open access
PDF file
MTMarek Tomkow
Marek Tomkow
Radosław BalwierzRadosław Balwierz
Radosław Balwierz
AMAdam Majewski
Adam Majewski
Aleksandra SzopaAleksandra Szopa
Aleksandra Szopa
The Pharmaceutical Law Act of September 6, 2001 (PLA) initially granted pharmacists the authority to issue pharmaceutical prescriptions upon its enactment. However, the legislation regulating this matter changed significantly in 2015. Article 96, section 4 of the PLA defined that, in the front of a direct health threat to a patient, a pharmacist could dispense a medication classified under the availability categories Rp or Rpz. In April 2020, the imprecise term “sudden” in relation to health threats was clarified and removed. Concurrently, all active pharmacists were granted the authority to issue prescriptions, commonly known as pro auctore and pro familiae. The aim of the study was to illustrate the influence of legislative processes on the number of prescriptions issued by practicing pharmacists. To conduct the study, we employed a legal and comparative analysis of relevant legal provisions, followed by a statistical analysis of data obtained from the E-Health Center about the number of prescriptions issued. The results indicated that since the extension of pharmacists’ rights (after April 2020), the average number of pharmaceutical prescriptions issued per month was 151,082. Between May 2020, when pharmacists were granted the authority to issue pro auctore and pro familiae prescriptions, and October 2023, 1,460,385 such prescriptions were dispensed. As a result, a significant relationship between the form of the legislative norms empowering pharmacists to independently prescribe Rx status medicines and the effectiveness of these amendments as measured by the number of prescriptions issued was demonstrated.